Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROCTER & GAMBLE Co Board/Management Information 2025

Jun 9, 2025

29757_rns_2025-06-09_55db8aff-338d-495b-8c53-206523086beb.zip

Board/Management Information

Open in viewer

Opens in your device viewer

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): June 9, 2025

THE PROCTER & GAMBLE COMPANY

(Exact Name of Registrant as Specified in Its Charter)

Ohio 001-00434 31-0411980
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

One Procter & Gamble Plaza , Cincinnati Ohio 45202

(Address of principal executive offices, including zip code)

513 - 983-1100

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock without Par Value PG NYSE
0.110% Notes due 2026 PG26D NYSE
3.25% EUR Notes due 2026 PG26F NYSE
4.875% EUR notes due May 2027 PG27A NYSE
1.200% Notes due 2028 PG28 NYSE
3.150% EUR Notes due 2028 PG28B NYSE
1.250% Notes due 2029 PG29B NYSE
1.800% Notes due 2029 PG29A NYSE
6.250% GBP notes due January 2030 PG30 NYSE
0.350% Notes due 2030 PG30C NYSE
0.230% Notes due 2031 PG31A NYSE
3.25% EUR Notes due 2031 PG31B NYSE
5.250% GBP notes due January 2033 PG33 NYSE
3.200% EUR Notes due 2034 PG34C NYSE
1.875% Notes due 2038 PG38 NYSE
0.900% Notes due 2041 PG41 NYSE

| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act
of 1934 (§240.12b-2 of this chapter). | |
| --- | --- |
| Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On June 9, 2025, the Board of Directors of The Procter & Gamble Company (the “Company”) appointed Craig Arnold, former Chairman and Chief Executive Officer of Eaton Corporation, as a Director of the Company, effective June 9. Mr. Arnold will serve on the Audit and Compensation & Leadership Development Committees.

The Board has determined that Mr. Arnold is independent under the NYSE listing standards and the Company’s Independence Guidelines. Mr. Arnold will receive the same compensation as the other non-employee members of the Board of Directors, including a pro-rated annual RSU grant that reflects his June appointment date. The Company’s Director compensation program is described in the Company’s definitive proxy statement dated August 23, 2024.

The Company is filing the information under this item pursuant to Item 5.02(d), “Election of Directors.”

ITEM 7.01 REGULATION FD DISCLOSURE

The Company issued a news release on June 9, 2025, announcing the appointment of Mr. Arnold. A copy of this news release is furnished as Exhibit 99.1.

The Company is furnishing the information under this item, including Exhibit 99.1, pursuant to Item 7.01, “Regulation FD Disclosure.”

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(d) Exhibits

Exhibit Number Description
99.1 Director News Release by The Procter & Gamble Company dated June 9, 2025.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

THE PROCTER & GAMBLE COMPANY

BY: /s/ Sandra T. Lane

Sandra T. Lane

Assistant Secretary

June 9, 2025

INDEX TO EXHIBIT(S)

Exhibit Number Description
99.1 Director News Release Provided by The Procter & Gamble Company
dated June 9, 2025.